Conjyclear eye drops 5 ml

Tradename

Conjiclear

Conjyclear

Compound:

Each 1 ml drops contains:

Olopatadine 1 mg

Auxiliary components:

disodium phosphate dodecahydrate, sodium chloride, benzalkonium chloride, purified water.

Properties

Olopatadine is a potent, selective antiallergic/antihistamine agent with several distinct mechanisms of action. It counteracts the release of histamine (the main mediator of allergic reactions in humans) and prevents the stimulation of cytokine production by human conjunctival epithelial cells, which is caused by histamine. Data from in vitro studies indicate that the drug acts on mast cells of the human conjunctiva, inhibiting the release of inflammatory mediators. It has been noted that topical ophthalmic use of the drug in patients with preserved nasolacrimal duct patency reduces the nasal signs and symptoms that often accompany seasonal allergic conjunctivitis. The drug does not cause clinically significant changes in pupil diameter.

Indications

Treatment of seasonal allergic conjunctivitis.

Dosage and administration

Buried in the conjunctival sac 1-2 times / day.

Contraindications

Hypersensitivity to olopatadine.

Precautionary measures:

Sufficient experience of use in children under the age of 3 years is not available. Can be used in children aged 3 years and older at the same doses as in adults.

Side effects

Local reactions: less than 5% — blurred vision, burning and pain in the eyes, lacrimation, sensation of a foreign body in the eye, conjunctival hyperemia, keratitis, iritis, swelling of the eyelids.

Systemic reactions: 0.1-1% — weakness, headache, dizziness, nausea, pharyngitis, rhinitis, sinusitis, change in taste.

Storage method: